New developments in infectious diseases for the critical care physician.
There have been numerous recent developments in the field of infectious diseases which are relevant to critical care medicine. These include a number of new syndromes, pathogens, and chemotherapeutic modalities. The purpose of this review is to summarize the most significant developments during the past 5 yr which are applicable to the practice of intensivists.
D000163:Acquired Immunodeficiency Syndrome / Q000453:epidemiology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D001906:Botulism / Q000453:epidemiology; D002675:Child, Preschool; D003015:Clostridium Infections / Q000150:complications; D003092:Colitis / Q000453:epidemiology / Q000209:etiology; D003141:Communicable Diseases / Q000188:drug therapy / Q000453:epidemiology / Q000401:mortality; D004196:Disease Outbreaks / Q000453:epidemiology; D005260:Female; D006801:Humans; D007875:Legionella / Q000472:pathogenicity; D007877:Legionnaires' Disease / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D012772:Shock, Septic / Q000453:epidemiology; D013211:Staphylococcus aureus / Q000472:pathogenicity; D013630:Tampons, Surgical / Q000009:adverse effects; D014481:United States; D014612:Vaccines / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D000998:Antiviral Agents; D014612:Vaccines